[1]
“Incidence of Adverse Events Related to Therapies with sodium iodine (131I): Contribution to the Pharmacovigilance in Brazil”, Braz. J. Rad. Sci., vol. 12, no. 3, p. e2481, Sep. 2024, doi: 10.15392/2319-0612.2024.2481.